Korsana (KRSA) Director Pernice Receives Stock Option Award

What Happened

• Pernice Michelle Patricia, a director of Korsana Biosciences, was granted a derivative award on 2026-09-09: the right to purchase 48,445 shares of Korsana common stock at $0.00 per share (reported as an Award/Grant).
• The filing shows no cash paid for the grant (acquisition price $0.00) — this is a compensation award, not an open-market purchase or sale.

Key Details

• Transaction date: 2026-09-09; Form 4 filed: 2026-09-10 (timely filing).
• Instrument: derivative award/option to acquire 48,445 shares; reported acquisition price: $0.00.
• Vesting: per footnote F1, the option vests in equal monthly installments through September 9, 2029, subject to continued service.
• Shares owned after the transaction: not specified in the summary provided.
• No 10b5-1 plan, sale, exercise, tax-withholding, or late-filing flag noted in the filing.

Context

• This grant is a typical director compensation award: it gives the right to purchase shares in the future as they vest rather than indicating an immediate market buy or sell.
• Because the award vests over time and has a $0.00 per-share acquisition price, the economic benefit depends on future vesting and any future exercise or conversion; it is not an immediate cash transaction.